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Abstract 
Objective: To describe the extensiveness of using medications that interact with alcohol or 
for which alcohol reduces the medication’s efficacy in older adults consuming alcohol at 
hazardous levels.    
Method: Retrospective file audit of patients discharged from Australia’s only older adult-
specific alcohol and other drug treatment service.      
Results: 72 patients aged between 58-years and 87-years (M=65.88; SD=5.67) drinking 
alcohol at hazardous or harmful levels were taking between 1 and 12 pharmaceutical drugs 
(M=4.03; SD=2.42). The majority (92%) of patients were taking at least one medication that 
placed them at high risk of serious adverse side effects when consumed with alcohol. The 
efficacy of most patients’ (97%) medication was deemed to be significantly reduced when 
consumed with alcohol.   
Conclusions: Among older adults who consume alcohol at hazardous levels, many take 
prescribed medications that adversely interact with alcohol or have reduced efficacy when 
consumed alongside alcohol. Targeted education is required for patients and healthcare 
workers to mitigate these risks.  
Key words: Adverse Drug Event, Drug Interactions, Polypharmacy, Alcohol Drinking, 
Alcohol Use Disorder. 
Practice Impact Statement: In a medications audit of patients with hazardous drinking, 
usage of medications that could adversely interact with alcohol or for which the efficacy 
could be compromised was common. Given rates of hazardous and harmful drinking among 
older Australians are increasing, targeted education to healthcare workers is required to 
reduce the risk of adverse drug events and improve treatment efficacy.     
Medication Use among Older Australians seeking Alcohol and Other Drug Treatment 
Older adults are at increased risk of adverse drug events and comorbidity due to: (i) 
increased prescribing and subsequent polypharmacy [1], and (ii) prescribing cascades.     
A prescribing cascade occurs “when a new medicine is prescribed to 'treat' an adverse 
reaction to another drug in the mistaken belief that a new medical condition requiring 
treatment has developed” [2, p.162]. This newly prescribed medication may produce a new, 
adverse reaction that is perceived as an additional medical condition.  
Alcohol can contribute to the prescribing cascade. For example, a protein pump 
inhibitor such as esomeprazole might be prescribed to treat gastric symptoms. However, the 
efficacy of protein pump inhibitors is reduced with concurrent alcohol consumption [3]. The 
excessive gastric acid could lead to a stomach ulcer requiring additional medications, such as 
analgesics, which often interact with alcohol causing respiratory depression and an increased 
risk of falls. Similarly, nitrates might be prescribed to treat angina caused by heart disease. 
Alcohol consumed alongside nitrates can lead to enhanced vasodilation and result in severe 
hypotension and headaches [4]. These symptoms could lead to a fall and the subsequent use 
of analgesics. 
In most Western countries, rates of hazardous and harmful alcohol consumption have 
increased significantly among older adults [5], increasing the risk of adverse drug events. 
Research examining the National Health and Nutrition Examination Survey (NHANES) 
found that among 3,408 people aged 65 or older who had consumed alcohol in the past 12 
months, 77.8% were taking medications that could interact with alcohol [6]. The most 
common medications were cardiovascular agents (61.3%), metabolic agents (36.5%), central 
nervous system agents (22.4%) and psychiatric medications (9.6%). Yet many healthcare 
professionals do not ask older adult patients about their alcohol consumption [7]. 
Despite older adults who drink alcohol at harmful levels being the most likely 
population to experience alcohol-related adverse medication interactions, there is limited 
research about the use of medications in this population. A recent study of 16,838 patients 
accessing treatment services for a substance use disorder in the Netherlands found that older 
adults with a late-onset substance use disorder used three and half times more medications 
than both younger adults and older adults with an early-onset substance use disorder [7]. 
However, the study did not examine whether the patients’ medications had a high risk of 
interacting with alcohol, nor whether the use of alcohol might reduce the efficacy of the 
medications. The present study aimed to describe the extensiveness of medication use among 
older adults drinking at levels that placed them at-risk of experiencing alcohol-related harm. 
In doing so, we sought to improve on existing methodologies by classifying medications as 
low or high risk for eliciting an alcohol-related medication interaction and/or impacting on 
treatment efficacy.    
Method 
A retrospective medical chart audit of patients discharged over a 12-month period was 
undertaken at Australia’s only older adult-specific alcohol and other drug treatment service 
by two counsellors and two nurses. An external senior clinician supervised the data 
collection, cross-checked any outlying cases and made sure that data entries were consistent 
if queries concerning anomalous information emerged [8]. The study was conducted in 
accordance with the Declaration of Helsinki, and a waiver of consent was approved by 
Peninsula Health’s Human Research Ethics Committee (LRR/16/PH/14).  
The medications that patients reported taking were extracted as variables in the audit 
and were grouped according to their treatment indication. These categories included 
psychiatric, cardiac, hypertensive, analgesic, diabetic, statin, gastric and anticonvulsive. We 
included herbal medications as a separate category.  
The Monthly Index of Medical Specialties (MIMS) was used to classify each 
medication type as having a low or high risk of adversely interacting with alcohol. The 
MIMS only provides information on alcohol interactions for a limited number of medications 
[9]. Consequently, a nurse practitioner worked with a pharmacist to review literature to 
develop a table. Medication types were classified as having a low or high risk of adversely 
interacting with alcohol, in addition to whether or not alcohol consumption would impact the 
medications’ efficacy (see Table 1).   
Finally, the primary drug of concern was determined by the severity of alcohol use, as 
measured by the Alcohol Use Disorders Identification Test – Consumption (AUDIT-C) [10]. 
Scores on the AUDIT-C can range between 0 and 12. The AUDIT-C has been shown to have 
better psychometric properties among older adults than the full AUDIT when a cut off score 
of 3 is used to identify risky drinking [11].  
Results 
A total of 79 charts were audited. Five patients were excluded since they had AUDIT-
C scores of less than 3. Two patients were excluded as there was missing data for the 
AUDIT-C. The remaining sample included 41 males aged between 58 and 77-years 
(M=65.76; SD=4.94) and 31 females aged between 58 and 87-years (M=66.03; SD=6.58).  
The primary drug of choice for all but one patient was alcohol. Their AUDIT-C 
scores ranged between 5 and 12 (M=11.3; SD=1.5). One patient was primarily seeking 
treatment for cannabis use and had an AUDIT-C score of 5.  
The total number of medications taken by patients ranged between 1 and 15 (M=5.18; 
SD=2.79). Patients reported taking between 1 and 12 pharmaceutical drugs (M=4.03; 
SD=2.42). The number of prescribed medications was correlated with age r = .30, p = 0.01.    
The most common medication types were for the treatment of psychiatric disorders 
(69%), gastric disorders (47%), hypertension (43%) and cholesterol (33%). Table 1 shows the 
frequencies of the medications patients reported taking and the risk ranking for each 
medication in terms of its potential to adversely interact with alcohol or for alcohol 
consumption to reduce its efficacy. Forty-six patients reported use of between 1 and 5 herbal 
supplements (M=1.80; SD=1.08). The types of herbal supplements were not recorded. There 
was no association between age or gender and the number of herbal supplements taken, and it 
was not possible to determine the impact of their relationship with alcohol consumption. 
Table 2 demonstrates most patients (92%) were taking at least one medication that 
placed them at high risk of serious adverse side effects when consumed with alcohol. The 
efficacy of most patients’ (97%) medication was deemed to be significantly reduced when 
consumed with alcohol. Given the low number of patients taking medications classified as 
low risk, Kruskal Wallis tests were used to examine differences between groups of 
participants who were taking a medication that had a low risk of adversely interacting with 
alcohol, a high risk of interacting with alcohol, a low risk of impacting the treatment’s 
efficacy and a high risk of impacting the treatment’s efficacy. No differences in AUDIT-C or 
age were observed.  
Discussion 
The extent of pharmaceutical medication use among older adults attending alcohol 
and other drug treatment services in Australia and deemed to be drinking at hazardous levels 
was high. One patient was taking 12 medications. Through determining the degree that these 
medications could produce severe adverse effects with concomitant alcohol use, we have 
found that many psychiatric, cardiovascular, analgesic, bladder and diabetic medications have 
a high risk of interacting with alcohol. These same medications, with the exception of 
analgesics and the inclusion of gastric medications, have a high risk of negatively impacting 
treatment efficacy when used with alcohol.  
Over 90% of patients were taking at least one medication deemed to have serious 
adverse side effects when consumed with alcohol, which was higher than 77.8% of 
participants identified in the NHANES [6]. This might reflect the finding that older people 
who are engaging in hazardous alcohol consumption are more likely to experience diverse 
medical co-morbidities [7], increasing their overall likelihood of taking a medication. 
Alternatively, given the threshold for inclusion of medications that could interact with 
alcohol was low in the analysis of the NHANES data, previous estimates of medication usage 
among older people who drink might be low. Those medications we classified as high risk 
could led to a range of potential adverse events due to varying and disparate mechanisms of 
action. It is important that clinicians are aware of the range of potential adverse events to best 
assess for symptoms.         
As our study only included people accessing one alcohol or other drug treatment 
service, we only obtained a small sample size, limiting the degree of confidence that our 
findings are representative of older adults drinking at hazardous and harmful levels. Further 
research using larger samples is required to improve understanding of the extent of 
medications used by older adults who drink that could adversely interact with alcohol.   
We are the first researchers to classify medications according to the impact alcohol 
has on their therapeutic efficacy among older adults. Almost 95% of our sample were taking 
at least one medication for which the efficacy of its therapeutic effect would be compromised 
by consuming alcohol. Further research investigating medication use among people who 
consume alcohol should consider the impact of alcohol on medication efficacy. There are 
various mechanism that might reduce the efficacy of medications that we classified as high 
risk and clinicians should be familiar with these since changes in prescribing practices might 
improve medication efficacy (e.g., higher dose). Given that many patients were found to be 
taking herbal supplements and as these can interact with alcohol [12], future research should 
also consider the risk of consuming specific herbal supplements alongside alcohol. 
Our findings suggest the need for multidisciplinary teams within alcohol and other 
drug treatment services to identify patients taking medications with a high risk of adversely 
interacting with alcohol. All patients reported taking at least one medication, which implies 
adherence to prescribed medications. While this is a positive finding, patients who drink 
alcohol and adhere to prescribed medications could be at greater risk of adverse medication 
interactions with alcohol than patients who modify consumption of or abstain from their 
prescribed medications for the purposes of consuming alcohol and controlling the interaction 
effects. Multidisciplinary teams could also reduce polypharmacy through medication reviews, 
aiming to identify evidence of past prescribing cascades. This could reduce the number of 
medications that patients are prescribed and reduce the likelihood of adverse drug events. For 
some patients, harm reduction strategies could be implemented where the aim is to reduce 
potential harms from substance use without necessarily requiring a reduction in their levels of 
substance use [13]. Patients could be prescribed medications that are less likely to have a 
serious adverse reaction when alcohol is consumed. For patients with less risky medications 
available to treat their medical condition, awareness of alcohol-medication interaction harms 
could be incentivise alcohol consumption reduction.  
As many healthcare professionals do not ask older adult patients about alcohol use 
[7], there is a need for increased education regarding the increasing extensiveness of 
hazardous and harmful alcohol use among older adults and the potential for alcohol-
medication interaction harms. Healthcare professionals should be encouraged to use 
screening tools that assess medication use, such as the Alcohol Related Problems Survey 
(ARPS)[9] or its Australian version (A-ARPS). Public heath campaigns for older adults 
should be developed that highlight common medications that adversely interact with alcohol 
or have reduced efficacy when consumed alongside alcohol, whilst recommending that older 
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Tables and Figures 
Table 1. Risk Classification of Medications. 
Medication (N, % cases) Risk of Adverse Event Impact on Treatment Efficacy 
Psychiatric 
Typical antipsychotic (n=2; 2.8%) 
Atypical antipsychotic (n=4; 5.6%) 
Tricyclic antidepressant (n=7; 9.7%) 
SSRI (n=29; 40.3%) 
SNRI (n=12; 16.7%) 
Mood Stabilisers (n=5; 6.9%) 
Benzodiazepine (n=14; 19.4%) 




















ACE Inhibitors (n=21; 29.2%) 
Ca Channel Blockers, including 
Verapamil (n=8; 11.1%) 
Beta Blockers (n=8; 11.1%) 
Angiotensin Receptor Blockers 
(n=2; 2.8%) 
Aspirin (n=5; 6.9%) 
Digoxin (n=3; 4.2%) 
Nitrates (n=4; 5.6%) 
Statins (n=26; 36.1%) 


























Paracetamol (n=9; 12.5%) 
NSAIDs (n=5; 6.9%) 










Insulin (n=3; 4.2%) 
Metformin (n=5; 6.9%) 










Gastric Medication (n=34; 47.2%) 
Anticonvulsant (n=1; 1.4%) 












Table 2. Risk of Alcohol Interacting with Participants’ Medication or Reducing its Efficacy.  
 
Adverse Interaction H Df p 
Low High Total    
Treatment 
Efficacy 
Low 2 (2.8%) 0 (0%) 2 (2.8%) 22.63 1 <.001 
High 4 (5.6%) 66 (91.7%) 70 (97.2%)    
Total 6 (8.3%) 66 (91.7%) 72 (100%)    
 
 
